Incyte INCY
NASDAQ INCY
$113.44 -3.17 (-2.72%)
At close: Oct 21, 2026 · 4:00 PM EDT

Incyte (INCY) Restructuring Costs (2016)

Updated

Incyte (INCY) posted Restructuring Costs of $100,000 for Q4 2016, down 93.3% from the prior quarter.

Analysis

Incyte (INCY) Restructuring Costs (2016) Analysis & Trends

For FY2016, Incyte's Restructuring Costs came in at $1.6 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Incyte 22.74 Bn 7.67 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 100,000.00
Sep 30, 2016 1.50 Mn
Jun 30, 2016 1.30 Mn
API Access

Incyte Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=INCY&period=max&api_key=YOUR_API_KEY